autmation

Sales & Marketing

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs).

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.